BM | PB | |||
---|---|---|---|---|
CD4+ | Femur | Iliac crest | P# | |
(n = 8) | (n = 8) | (n = 16) | ||
% CCR7+CD45RA+ (TN) | 26.1 ± 2.3 | 19.8 ± 1.9 | 0.08 | 34.8 ± 2.9*/§ |
%CCR7+CD45RA- (TCM) | 21.9 ± 5.9 | 24.4 ± 3.1 | 0.89 | 28.8 ± 3.7 |
% CCR7-CD45RA- (TEM) | 34.6 ± 4.4 | 44.3 ± 3.6 | 0.11 | 23.8 ± 3.3*/§ |
%CCR7-CD45RA+ (TEMRA) | 12.1 ± 3.3 | 13.4 ± 3.0 | 0.80 | 15.7 ± 2.7 |
CD69 | 16.9 ± 3.1 | 15.9 ± 2.3 | 0.69 | 0.7 ± 0.1*/§ |
CD8 + | Femur | Iliac crest | ||
(n = 8) | (n = 8) | (n = 16) | ||
% CCR7+CD45RA+ (TN) | 17.8 ± 3.5 | 14.1 ± 3.2 | 0.47 | 29.3 ± 3.4*/§ |
%CCR7+CD45RA- (TCM) | 16.7 ± 3.1 | 10.9 ± 4.1 | 0.68 | 14.5 ± 2.2 |
% CCR7-CD45RA- (TEM) | 29.1 ± 4.2 | 34.1 ± 6.7 | 0.64 | 21.9 ± 2.6*/§ |
%CCR7-CD45RA+ (TEMRA) | 33.0 ± 0.5 | 41.6 ± 5.9 | 0.59 | 39.5 ± 3.7 |
CD69 | 39.0 ± 6.1 | 46.3 ± 4.1 | 0.59 | 1.9 ± 0.4*/§ |